New approaches to cancer care in a COVID-19 world

John Butler, Christian Finley, Charles H. Norell, Samantha Harrison, Heather Bryant, Michael P. Achiam, Alon D. Altman, Nancy Baxter, James Bentley, Paul A. Cohen, M. Asif Chaudry, Elijah Dixon, Rhonda Farrell, Scott Fegan, Salila Hashmi, Claus Hogdall, John T. Jenkins, Janice Kwon, Tom Mala, Orla McNallyNeil Merrett, Gregg Nelson, Andy Nordin, Jason Park, Geoff Porter, John Reynolds, Colin Schieman, Tine Schnack, Allan Spigelman, Lars Bo Svendsen, Peter Sykes, Robert Thomas

Research output: Contribution to journalArticlepeer-review

17 Citations (Scopus)

Abstract

The effects of COVID-19 on cancer are substantial, highlighting both novel and existing challenges for health-care systems. We were therefore encouraged to see The Lancet Oncology's call for cancer care to be safeguarded in a postCOVID-19 world.1 We endorse this position for cancer surgery specifically, and propose several recommendations aiming to reduce the so-called collateral damage of COVID-19. The International Cancer Benchmarking Partnership (ICBP) is a global collaboration seeking to compare and improve cancer survival across high income countries.2 Within the ICBP, we came together to provide a voice for the international cancer surgery community.
Original languageEnglish
Pages (from-to)e339-e340
Number of pages2
JournalThe Lancet Oncology
Volume21
Issue number7
DOIs
Publication statusPublished - 2020

Keywords

  • COVID-19 (disease)
  • cancer
  • pandemics

Fingerprint

Dive into the research topics of 'New approaches to cancer care in a COVID-19 world'. Together they form a unique fingerprint.

Cite this